Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-22-021567
Filing Date
2022-03-30
Accepted
2022-03-30 07:20:14
Documents
1
Period of Report
2022-03-29

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3166
  Complete submission text file 0001209191-22-021567.txt   4722
Mailing Address 4350 LA JOLLA VILLAGE DRIVE SUITE 800 San Diego CA 92122
Business Address 4350 LA JOLLA VILLAGE DRIVE SUITE 800 San Diego CA 92122 858-550-0780
Tracon Pharmaceuticals, Inc. (Issuer) CIK: 0001394319 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O TRACON PHARMACEUTICALS, INC. 4350 LA JOLLA VILLAGE DRIVE, SUITE 800 SAN DIEGO CA 92122
Business Address
Brown Scott B. (Reporting) CIK: 0001789822 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36818 | Film No.: 22783101